ROLE OF SUBSTRATE LIPOPHILICITY IN DETERMINING TYPE-1 MICROSOMAL P450 BINDING CHARACTERISTICS

被引:58
作者
ALGAILANY, KAS [1 ]
HOUSTON, JB [1 ]
BRIDGES, JW [1 ]
机构
[1] UNIV SURREY,DEPT BIOCHEM,GUILDFORD GU2 5XH,SURREY,ENGLAND
关键词
D O I
10.1016/0006-2952(78)90521-X
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The Type 1 cytochrome P450 binding of 53 aliphatic, alicyclic and aromatic compounds to microsomes from phenobarbitone or 3 methylcholanthrene pre-treated or normal hamsters has been studied. A good correlation between binding affinity and substrate lipophilicity was observed for each series of compounds. Sterically hindered molecules tended to partially deviate from this relationship. The pronounced slopes of plots of Ks against log P indicate that substrate lipophilicity is the predominant requirement for Type 1 binding of these compounds. Microsomes from phenobarbitone pre-treated animals showed very similar substrate binding characteristics to those of normal animals whilst 3-methylcholanthrene pre-treated animals showed a spectral shift but similar binding affinities. © 1978.
引用
收藏
页码:783 / 788
页数:6
相关论文
共 29 条
[1]
AL-GAILANY K A S, 1974, Biochemical Society Transactions, V2, P113
[2]
DEALKYLATION OF SOME PARA-NITROPHENYLALKYLETHERS AND THEIR ALPHA-DEUTERATED ANALOGS BY RAT-LIVER MICROSOMES [J].
ALGAILANY, KAS ;
BRIDGES, JW ;
NETTER, KJ .
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (08) :867-870
[3]
ANDERS MW, 1973, DRUG METAB DISPOS, V1, P642
[4]
CORRELATION OF SERUM BINDING OF PENICILLINS WITH PARTITION COEFFICIENTS [J].
BIRD, AE ;
MARSHALL, AC .
BIOCHEMICAL PHARMACOLOGY, 1967, 16 (12) :2275-&
[5]
BROWN NL, UNPUBLISHED
[6]
BIPHENYL HYDROXYLATIONS AND SPECTRALLY APPARENT INTERACTIONS WITH LIVER-MICROSOMES FROM HAMSTERS PRETREATED WITH PHENOBARBITONE AND 3-METHYLCHOLANTHRENE [J].
BURKE, MD ;
BRIDGES, JW .
XENOBIOTICA, 1975, 5 (06) :357-376
[7]
PARTITION MODEL FOR HEPATIC CYTOCHROME P-450-HYDROCARBON COMPLEX-FORMATION [J].
CANADY, WJ ;
ROBINSON, DA ;
COLBY, HD .
BIOCHEMICAL PHARMACOLOGY, 1974, 23 (21) :3075-3078
[8]
COHEN GM, 1973, MOL PHARMACOL, V9, P383
[9]
DICKINS M, UNPUBLISHED
[10]
GAYLOR JL, 1970, J BIOL CHEM, V245, P5511